Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma

Completed · Phase 2

Conditions studied: Melanoma, Metastases

In brief

This trial will treat patients previously treated for advanced (metastatic) melanoma (skin cancer) with a new chemotherapeutic medicine. The new chemotherapy will be administered weekly in cycles of three weekly doses followed by one week rest. A minimum of three cycles of therapy will be given to determine the anti-tumor response of the new chemotherapy. Patients may continue to stay on therapy a maximum of 9-12 cycles if treatment shows continuing benefit.

Key facts

Study ID

NCT00093119

Run by

Celgene

People needed

75

Starts

2003-07-01

Last updated by the study team

2017-04-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Confirmed Metastatic Melanoma
• At least 18 years old
• No other active malignancy
• Hemoglobin at least 9
• Platelet Count at least 100,000 cells/mm3
• ANC at least 1500 cells/mm3
• AST \& ALT less than 2.5X upper limit of normal
• Total bilirubin less than 1.5mg/dL
• Creatine less than 1.5 mg/dL
• Alkaline phosphatase less than 2.5X upper limit of normal
• Life expectancy of at least 12 weeks
• ECOG performance status of 0-1
• Patient must provide informed consent
• Patient must provide authorization to disclose

You may not qualify if…

• Evidence of active brain metastases
• The only evidence of metastasis is lytic or blastic bone metastases
• Pre-existing peripheral neuropathy of NCI Toxicity Criteria Scale of grade greater than 2
• Received radiotherapy in last 4wks, except if to a non-target lesion only
• Clinically significant concurrent illness
• Investigator's opinion that patient unlikely to complete study
• Cytotoxic chemotherapeutic agent treatment or investigational drug within previous 4wks
• History of allergy/hypersensitivity to study drug
• Serious Medical Risk Factors determine by the investigator

Where it is running

• Abraxis BioScience Inc. — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.